J. Ferlay, E. Steliarova-foucher, J. Lortet-tieulent, S. Rosso, J. W. Coebergh et al., Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012, Eur. J. Cancer, vol.49, pp.1374-1403, 2013.

C. M. Perou, T. B. Sorlie, C. Eisen, M. Van-de-rijn, S. S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, pp.747-752, 2000.

T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. S. Marron et al., Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc. Natl. Acad. Sci, vol.100, pp.8418-8423, 2003.

J. S. Reis-filho and A. N. Tutt, Triple negative tumours: A critical review: Triple negative tumours, Histopathology, vol.52, pp.108-118, 2007.

R. Dent, M. Trudeau, K. I. Pritchard, W. M. Hanna, H. K. Kahn et al., Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence, Clin. Cancer Res, vol.13, pp.4429-4434, 2007.

B. G. Haffty, Q. Yang, M. Reiss, T. Kearney, S. A. Higgins et al., Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer, J. Clin. Oncol, vol.24, pp.5652-5657, 2006.

G. Lorusso and C. Rüegg, New insights into the mechanisms of organ-specific breast cancer metastasis, Semin. Cancer Biol, vol.22, pp.226-233, 2012.

A. J. Minn, G. P. Gupta, P. M. Siegel, P. D. Bos, W. Shu et al., Genes that mediate breast cancer metastasis to lung, Nature, vol.436, 2005.

Q. Chen and J. Massague, Molecular Pathways: VCAM-1 as a Potential Therapeutic Target in Metastasis, Clin. Cancer Res, vol.18, pp.5520-5525, 2012.

J. M. Cook-mills, M. E. Marchese, and H. Abdala-valencia, Vascular cell adhesion molecule-1 expression and signaling during disease: Regulation by reactive oxygen species and antioxidants, Antioxid. Redox Signal, vol.15, pp.1607-1638, 2011.

M. Schlesinger and G. Bendas, Vascular cell adhesion molecule-1 (VCAM-1)-An increasing insight into its role in tumorigenicity and metastasis: VCAM-1 in tumorigenicity, Int. J. Cancer, vol.136, pp.2504-2514, 2015.

Y. Maimaiti, C. Wang, M. Mushajiang, J. Tan, B. Huang et al., Overexpression of VCAM-1 is correlated with poor survival of patients with breast cancer, Int. J. Clin. Exp. Pathol, vol.9, pp.7451-7457, 2016.

X. Lu, E. Mu, Y. Wei, S. Riethdorf, Q. Yang et al.,

, Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging ?4?1-Positive Osteoclast Progenitors, Cancer Cell, vol.20, pp.701-714, 2011.

Q. Chen, X. H. Zhang, .. Massagué, and J. , Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs, Cancer Cell, vol.20, pp.538-549, 2011.

Y. Kang, Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis, Endocrinol. Metab, vol.31, p.206, 2016.

H. Cao, Z. Zhang, S. Zhao, X. He, H. Yu et al., Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression, J. Control. Release, vol.205, pp.162-171, 2015.

T. Wu, The Role of Vascular Cell Adhesion Molecule-1 in Tumor Immune Evasion, Cancer Res, vol.67, pp.6003-6006, 2007.

K. Lin, D. Lu, C. Hung, S. Peng, L. Huang et al., Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune Evasion, Cancer Res, vol.67, pp.1832-1841, 2007.

P. Wang, C. Weng, Y. Hou, S. Jian, K. Fang et al., Activation of VCAM-1 and Its Associated Molecule CD44 Leads to Increased Malignant Potential of Breast Cancer Cells, Int. J. Mol. Sci, vol.15, pp.3560-3579, 2014.

A. Broisat, S. Hernot, J. Toczek, J. De-vos, L. M. Riou et al., Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions, Circ. Res, vol.30, pp.927-937, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00831749

L. S. Dumas, F. Briand, R. Clerc, E. Brousseau, C. Montemagno et al., Evaluation of Antiatherogenic Properties of Ezetimibe Using 3 H-Labeled Low-Density-Lipoprotein Cholesterol and 99m Tc-cAbVCAM1-5 SPECT in ApoE ?/? Mice Fed the Paigen Diet, J. Nucl. Med, vol.58, pp.1088-1093, 2017.

A. B. Mariotto, R. Etzioni, M. Hurlbert, L. Penberthy, and M. Mayer, Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States, Cancer Epidemiol. Biomark. Prev, vol.26, pp.809-815, 2017.

E. Group, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials, Lancet, vol.365, pp.1687-1717, 2005.

B. L. Eckhardt, P. A. Francis, B. S. Parker, and R. L. Anderson, Strategies for the discovery and development of therapies for metastatic breast cancer, Nat. Rev. Drug Discov, vol.11, pp.479-497, 2012.

R. Sharma, R. Sharma, T. P. Khaket, C. Dutta, B. Chakraborty et al., Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1, Cell Oncol, vol.40, pp.199-208, 2017.

Y. Ding, G. Chen, J. Xia, X. Zang, H. Yang et al., Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma, World J. Gastroenterol, vol.9, 1409.

Y. Liu, H. Lin, S. Lai, C. Huang, B. Huang et al., MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma, vol.36, pp.5006-5022, 2017.

J. Huang, J. Zhang, H. Li, Z. Lu, W. Shan et al., VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer, Am. J. Transl. Res, issue.5, p.336, 2013.

X. Zhang, C. Liu, F. Hu, Y. Zhang, J. Wang et al., Imaging of VCAM-1 Expression and Monitoring Therapy Response in Tumor with a 68 Ga-Labeled Single Chain Variable Fragment, Mol. Pharm, vol.15, pp.609-618, 2018.

J. M. Scalici, S. Thomas, C. Harrer, T. A. Raines, J. Curran et al., Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer, J. Nucl. Med, vol.54, pp.1883-1889, 2013.

A. Broisat, J. Toczek, L. S. Dumas, M. Ahmadi, S. Bacot et al., 99mTc-cAbVCAM1-5 Imaging Is a Sensitive and Reproducible Tool for the Detection of Inflamed Atherosclerotic Lesions in Mice, J. Nucl. Med, vol.55, pp.1678-1684, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01077899

S. Rajan, J. Ye, S. Bai, F. Huang, and Y. Guo, NF-?B, but not p38 MAP Kinase, is required for TNF-?-induced expression of cell adhesion molecules in endothelial cells, J. Cell. Biochem, vol.105, pp.477-486, 2008.

B. Li, A. Vincent, J. Cates, D. M. Brantley-sieders, D. B. Polk et al., Low Levels of Tumor Necrosis Factor Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site, Cancer Res, vol.69, pp.338-348, 2009.

X. Cai, C. Cao, J. Li, F. Chen, S. Zhang et al., Inflammatory factor TNF-alpha promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-?B (and/or p38, Oncotarget, vol.8, pp.58338-58352, 2017.

, The cBioPortal for Cancer Genomics, p.19, 2019.

E. Cerami, J. Gao, U. Dogrusoz, B. E. Gross, S. O. Sumer et al., The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1. Cancer Discov, vol.2, pp.401-404, 2012.

J. Gao, B. A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross et al., Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal, Sci. Signal, issue.6, 2013.